IFIT3 and hepatocellular carcinoma: IFIT3, whose expression in HCC tissue samples compared to normal ones is decreased [34,50], similar to IFIT2, has been reported to be a good prognostic factor for HCC with improved overall survival and PFS outcomes [50].